Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
The Lancet Microbe2021Vol. 2(6), pp. e240–e249
Citations Over TimeTop 1% of 2021 papers
Wan Ni Chia, Feng Zhu, Sean Wei Xiang Ong, Barnaby Edward Young, Siew‐Wai Fong, Nina Le Bert, Chee Wah Tan, Charles Kevin Tiu, Jinyan Zhang, Seow Yen Tan, Surinder Pada, Yi‐Hao Chan, C Tham, Kamini Kunasegaran, Mark Chen, Jenny G. Low, Yee‐Sin Leo, Laurent Rénia, Antonio Bertoletti, Lisa F. P. Ng, David Chien Lye, Lin‐Fa Wang
Abstract
National Medical Research Council, Biomedical Research Council, and A*STAR, Singapore.
Related Papers
- → Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies(2012)218 cited
- → Impact of HIV Subtype on Performance of the Limiting Antigen-Avidity Enzyme Immunoassay, the Bio-Rad Avidity Assay, and the BED Capture Immunoassay in Rakai, Uganda(2013)36 cited
- → Clinical Differences between S.L.E. Patients in Relation to the Avidity of their Anti-dsDNA(1985)16 cited
- → A competition assay for antibody avidity(1976)4 cited
- → Nanoscale spatial dependence of avidity in an IgG1 antibody(2019)1 cited